Sitagliptin and Pioglitazone Mechanism of Action Study in Type 2 Diabetes Mellitus (0431-061)
Clinical trial NCT00511108 · COMPLETED
Trial details
- NCT number
- NCT00511108
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-11
- Primary completion
- 2009-02-24
- Enrollment
- 211
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.